The prometastatic oncogene synuclein-c (SNCG) is not expressed in normal lung tissues, but it is highly expressed in lung tumors. Here, we show that cigarette smoke extract (CSE) has strong inducing effects on SNCG gene expression in A549 lung cancer cells through demethylation of SNCG CpG island. CSE treatment also augments the invasive capacity of A549 cells in an SNCG-dependent manner. To elucidate the mechanisms underlying the demethylating effects of CSE, we examined expression levels of DNA methyltransferases (DNMTs), 1, 3A and 3B in CSE-treated cells. We show that the mRNA expression of DNMT3B is specifically downregulated by CSE with a kinetics concurrent to SNCG reexpression. Utilizing siRNA to knockdown DNMT3B expression, we show that inhibition of DNMT3B directly increases SNCG mRNA expression. We further show that exogenous overexpression of DNMT3B in an SNCG-positive lung cancer cell line H292 suppresses SNCG mRNA and protein expression and induces de novo methylation of SNCG CpG island, whereas overexpression of DNMT1 or DNMT3A has no effects. Taken together, these new findings demonstrate that tobacco exposure induces the abnormal expression of SNCG in lung cancer cells through downregulation of DNMT3B. This work sheds light on the molecular understanding of demethylation of this oncogene during cancer progression.
Introduction
Lung cancer is the leading cause of cancer mortality in both men and women in the United States and now accounts for 30% of all deaths from cancer (Jemal et al., 2002) . It is also the leading cause of cancer-related deaths worldwide. The global rise in lung cancer incidence, together with poor survival rate (Belinsky, 2004) and refractory to traditional chemotherapy, underscores the magnitude of the lung cancer epidemic and the urgent need for a more thorough understanding of the mechanisms responsible for this malignancy (Schrump and Nguyen, 2005) . With this regard, identifications of key molecular targets and cellular pathways involved in pulmonary carcinogenesis would have significant therapeutic implications.
The human synuclein-g (SNCG) gene has been identified as a prometastatic oncogene by our laboratory and other investigators (Li et al., 2004; Liu et al., 2005; Zhao et al., 2006) . The normal expression of SNCG is restricted to the brain and periphery neuronal tissues (Lavedan et al., 1998) and its aberrant expression outside neuronal system is highly associated with human malignancies (Ji et al., 1997; Bruening et al., 2000; Wu et al., 2003; Yanagawa et al., 2004; Cao et al., 2005) . SNCG expression has been detected in nine different types of human cancers including lung cancer. SNCG is highly expressed in tumor tissues but not expressed in tumor-matched nonneoplastic adjacent tissues of lung cancer patients (Liu et al., 2005) . The SNCG expression in lung tumors shows a correlation with stage progression and metastasis. The exon 1 of SNCG gene contains a CpG island with 15 CpG dinucleotides (Lu et al., 2001) . By performing genomic sequencing and methylation-specific polymerase chain reaction (MSP) assays, we have shown that the SNCG CpG island is completely unmethylated in lung tumor samples as well as in other types of tumors, which is in sharp contrast to the predominantly methylated CpG island of SNCG in the majority of normal tissues adjacent to tumors (Liu et al., 2005) . These previous studies demonstrate that demethylation of the CpG island of SNCG gene is a primary determinant responsible for its aberrant expression in cancerous tissues. However, at present the molecular and cellular mechanisms underlying the cancer-associated loss of methylation control of SNCG gene remain largely undefined.
The vast majority of lung cancers are directly attributable to cigarette smoking (Thompson, 2005) . Tobacco, a rich resource of pulmonary carcinogens, is known to cause many genetic changes through DNA mutations (Hecht, 1999) . It has been also demonstrated that tobacco exposure induces epigenetic changes through promoter methylation of tumor suppressor genes (TSGs) Belinsky et al., 2003; Fujiwara et al., 2005) and proapoptotic genes (Pulling et al., 2004) . Increased expression of DNA methyltransferase 1 (DNMT1) has been linked to tobacco-caused hypermethylation of TSG RAS-association domain family 1A (RASSF1A) (Burbee et al., 2001) . DNMT1 is the most abundant form of DNMTs in mammalian cells. DNMT1 functions primarily in maintenance methylation during DNA replication using hemimethylated DNA as substrates (Lyko et al., 1999; Robertson et al., 1999; Rountee et al., 2000; Robert et al., 2003; Suzuki et al., 2004) . The reactions of de novo methylation using unmethylated DNA are thought to be primarily catalysed by DNMT3A and DNMT3B in mammals during early development (Okano et al., 1999; Bachman et al., 2001; Brueckner and Lyko, 2004; Hermann et al., 2004; Dodge et al., 2005) .
The purpose of this study was to investigate the possible role of cigarette smoke in causing the reexpression of the SNCG gene in lung cancer cells and the underlying molecular mechanisms. Our results provide the first evidence that cigarette smoke induces the demethylation and subsequent expression of SNCG gene in lung cancer cells through downregulation of DNMT3B.
Results
Silencing SNCG expression in A549 lung cancer cells through CpG island methylation The effect of tobacco exposure on SNCG expression was examined in two lung carcinoma cell lines, A549 and H292. A semiquantitative reverse transcriptionpolymerase chain reaction (RT-PCR) method was used to examine SNCG mRNA expression in these cells. SNCG mRNA was barely detectable in A549 cells, but was highly expressed in H292 cells (Figure 1a, left panel) . Western blot with anti-SNCG antibody further confirmed the expression of SNCG in H292 but not in A549 cells (middle panel). MSP on bisulfite-modified genomic DNAs isolated from A549 and H292 cells clearly shows that methylated SNCG alleles were predominant in A549 cells, whereas unmethylated SNCG alleles were common in H292 cells (right panel). We further carried out the genomic sequencing of SNCG CpG island in these two cell lines and the results in Figure 1b show that majority of the CpG dinucleotides within SNCG CpG island of A549 cells is in methylated status and all these CpG sites are demethylated in H292 cells. Thus, the results of MSP and genomic sequencing provide good correlations with the SNCG expression status.
The role of DNA methylation in silencing SNCG gene expression in A549 cells was evaluated further by treatment of cells with the demethylating agent 5-aza-2 0 -deoxycytidine (5-aza-C) (Brueckner and Lyko, 2004 ) for 4 and 6 days. Genomic DNA, total RNA and protein were isolated separately from untreated and treated cells. MSP indicated that treatment of cells with 5-aza-C at a dose of 5 mM induced a time-dependent demethylation of the SNCG CpG island. After 6 days of treatment, SNCG gene became fully demethylated (Figure 1c , left panel). Demethylation was closely accompanied by the expression of SNCG mRNA (middle panel) and protein (right panel). On the basis of these collective results, we conclude that SNCG expression is silent in A549 lung cancer cells due to gene methylation and that this cell line could serve as an in vitro model to study the regulatory effects of tobacco exposure on SNCG methylation status. Two micrograms of total RNA was used in the reaction of reverse transcription in a volume of 20 ml. Two microliters of the RT product was used in PCR with specific primers to SNCG or GAPDH. The RT-PCR products were separated on a 2% agarose gel and stained with ethidium bromide. SNCG protein expression in these two cell lines was examined by Western blot by using 50 mg of protein of total cell lysate. MSP was used to assess the methylation status of SNCG CpG island in A549 and H292 cells. M, methylated PCR product; U, unmethylated PCR product. (b) The entire map of CpG island from each cell line was obtained by genomic sequencing as described in the 'Materials and methods' section. Positions are indicated relative to the translation start codon, and each circle in the figure represents a single CpG site. For each cell line, six independent clones were sequenced and each row represents one clone. J, unmethylated; , methylated. (c) A549 cells were treated with 5 mM of 5-aza-C for 4 or 6 days. Genomic DNA, total RNA and cell lysates were separated at the end of treatment. The methylation status of SNCG CpG island was determined by MSP; SNCG mRNA and protein expressions were determined by RT-PCR and Western blot analysis.
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Cigarette smoke induces demethylation and expression of SNCG in A549 lung cancer cells Cigarette smoke extract (CSE) was added to culture medium of A549 cells at various final concentrations for 3 days. During the treatment, medium was changed daily with fresh CSE. At the end of treatment, treated and control cells were harvested as well as RNA and DNA were isolated. RT-PCR analysis revealed that 3-day exposure to CSE induced a significant dosedependent increase in the levels of SNCG mRNA in A549 cells (Figure 2a, left panel) . A notable increase of 2.9-fold was detected in cells treated with 0.6% CSE and the induction reached a plateau at a CSE concentration of 2.5%. The CSE-induced elevation of SNCG mRNA levels was further corroborated with a real-time RT-PCR assay. MSP analysis of the methylation status of SNCG demonstrated that CSE induced a dose-dependent conversion of the CpG island from heavily methylated in control cells to nearly completely demethylated in 2.5% CSE-treated cells (right panel).
Next, we examined the kinetics of CSE-induced demethylation and expression of SNCG. A549 cells were exposed to CSE (2.5%) for indicated time points before the isolations of DNA and RNA. CSE treatment induced a rapid demethylation of SNCG gene in A549 cells (Figure 2b, left panel) . A significant amount of demethylated alleles was detected after 1 day of exposure and the demethylated PCR product became the sole detected PCR product after 3 days of CSE treatment. The results of genomic sequencing of DNA samples isolated from CSE-treated A549 cells were consistent with the MSP and showed that over 73% of CpG dinucleotides within the CpG island became demethylated after CSE treatment for 3 days (Figure 2b, right panel) .
The induction of SNCG mRNA expression by CSE displayed almost identical kinetics as the demethylation of SNCG CpG island (Figure 2c, left panel) . In contrast to A549 cells, 5% CSE treatment for 3 days did not increase the level of SNCG mRNA in H292 cells in which the SNCG CpG island was already fully demethylated (right panel), providing additional evidence to support the hypothesis that CSE-induced SNCG expression is due to gene demethylation.
In addition to CSE, we also tested the effect of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) (Pulling et al., 2004) , a well-known tobacco carcinogen on SNCG gene expression in A549 cells. NNK induced SNCG gene expression to a lesser extent compared to CSE, suggesting that NNK, which is present in CSE, may be partially responsible for the demethylation effect ( Figure 2d ).
SNCG reexpression is an early response to tobacco exposure in lung cancer cells Tobacco exposure is known to cause hypermethylation of TSGs (Russo, 2005) . We examined the effects of CSE on the promoter methylation status of RASSF1A and O 6 -methylguanine-DNA methyltransferase (MGMT) as well as a prometastatic oncogene urokinase-type plasminogen (uPA) (Pakneshan et al., 2004) , along with SNCG in A549 cells using the method of multiplex, nested, two-step MSP (MNMSP). The MSP products obtained from step 2 of the nested MSP for the four genes are shown in Figure 3 . RASSF1A and MGMT were partially methylated in A549 cells without tobacco exposure; CSE treatment for 3 days did not further increase the degree of methylation. However, with a longer treatment of 6 days, these two genes became fully methylated. Interestingly, induction of promoter demethylation of uPA by CSE in these cells also required 6 days. Among the four genes examined, only the methylation status of SNCG rapidly changed with a full demethylation that occurred after 3 days of CSE treatment. These results demonstrate that tobacco exposure differentially affects the methylation status of TSGs and oncogenes.
Cigarette smoke stimulates A549 lung cancer cell invasion Because increased cell proliferation and invasion contribute prominently to the tobacco-induced pulmonary carcinogenesis, we tested the effects of cigarette smoke on the proliferation rate and the invasive behavior of A549 cells. To measure cell growth, A549 cells were seeded in 24-well culture plates and exposed to CSE at a concentration of 5% for a period of 1-3 days. At the indicated time points, cells were trypsinized and viable cells were counted. The proliferation of A549 cells were only slightly increased (o30%) in cells treated with CSE for 3 days (Figure 4a ). To determine whether CSE increases cell invasion, using two-compartment Boyden chambers and basement membrane matrigel, we examined the invasive capacities of A549 without and with CSE treatment of 3 days at 1.25 and 5% final concentrations. Control and CSE-treated cells were trypsinized. Fifty thousand cells were seeded onto the matrigel-coated top chamber and triplicate wells were set for each sample. Cells were allowed to migrate through the membrane for 40 h. CSE-induced a dosedependent increase in the numbers of invaded cells up to 3.8-fold of control ( Figure 4b ).
To determine if the expression of SNCG played a causal role in the CSE-augmented cell invasion, A549 cells were transfected with two predesigned small interference RNAs (siRNAs) targeted to SNCG or a control siRNA with scrambled sequence for 24 h before CSE treatment for 3 days. The results of invasion assays showed that in the absence of SNCG siRNA, CSE increased the number of invaded cells by 2. Together, these data suggest that SNCG has an intrinsic role in lung cancer cell invasion and its expression is largely responsible for the CSE-stimulated cell invasion in A549 cells.
Cigarette smoke differentially regulates DNMTs in A549 cells
Altered expressions of DNMTs have been linked to the cancer-associated hypermethylation of TSGs (Gius et al., 2004; Suzuki et al., 2004; Pruitt et al., 2005; Oka et al., 2006) , as well as the hypomethylation of melanoma antigen gene MAGE-A1 (Loriot et al., 2006) . We sought to determine which DNMT was involved in CSE-induced changes in the methylation pattern of SNCG. At first, we examined the protein levels of DNMT1, DNMT3A and DNMT3B in A549 cells treated with CSE for 1-3 days. Western blot analysis of total cell lysate using anti-DNMT1 showed a time-dependent induction of DNMT1 (Figure 5a ). However, owing to the low-level expressions, even using nuclear extracts, we could not detect clear signals of DNMT3A or DNMT3B on Western blots with any of the available commercial antibodies directed to these two enzymes. This was consistent with several literature reports that described the difficulties in the detection of DNMT3B and DNMT3A by Western blotting. Therefore, real-time quantitative RT-PCR assays with predeveloped probes to DNMT3A and DNMT3B mRNAs were conducted instead. The mRNA levels of DNMT3A in A549 cells were slightly increased by CSE treatment. Interestingly, we detected a time-dependent decrease in the levels of DNMT3B by CSE treatment (Figure 5b ) Figure 3 Effects of CSE on the methylation status of TSGs and prometastatic oncogenes. A549 cells were untreated or treated with 5% CSE for 3 or 6 days. Genomic DNA was isolated and modified by sodium bisulfite. MNMSP was conducted as described in the 'Materials and Methods' section. M, methylated PCR product; U, unmethylated PCR products.
Synuclein-c is a target gene of DNMT3B H Liu et al with kinetics inversely correlated with the induction of SNCG demethylation (Figure 2b ). Altogether, these data demonstrate that tobacco exposure has differential effects on the expressions of DNMTs.
Next, we performed a CSE-withdrawal experiment to examine further the relationship between the increased expression of SNCG with a decreased DNMT3B expression. A549 cells were treated with 5% CSE for 3 days and cells were re-cultured in fresh medium without CSE for 0-6 days. At indicated time points, cells were harvested and total RNA and genomic DNA were separately isolated. Figure 5c (top panel) shows the results of MSP. CSE treatment for 3 days resulted in a complete conversion of SNCG CpG island from methylated to unmethylated, which was accompanied with the strong expression of SNCG mRNA (middle panel) and a twofold decrease of DNMT3B mRNA level. The withdrawal of CSE from the medium released the repression on DNMT3B expression and this in turn was correlated with the reappearance of the methylated SNCG CpG island and the silencing of SNCG transcription. These data indicate that the removal of CSE released the repression on DNMT3B expression that rendered DNMT3B regains the methylation control over SNCG CpG island.
We further examined the effect of DNMT3B siRNA on SNCG expression. Two sets of DNMT3B siRNA were cotransfected into A549 cells and the mRNA levels of DNMT3B and SNCG were assessed by semiquantitative RT-PCR (Figure 5d , inset) and real-time quantitative RT-PCR (Figure 5d ). siRNA transfection resulted in a 75% reduction of DNMT3B mRNA level and a 4.5-fold increase in the mRNA level of SNCG compared to mock-transfected cells. 
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To demonstrate a direct role of DNMT3B in the control of SNCG methylation status, we transiently transfected a DNMT3B expression vector pcDNA-DNMT3B into H292 cells in which SNCG is completely unmethylated. After transfection, total RNA, genomic DNA and nuclear protein were isolated separately from transfected cells. RT-PCR assays showed that the mRNA level of DNMT3B was increased and the SNCG mRNA level was correspondingly decreased, whereas the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA expression was not changed in DNMT3B-transfected cells as compared to the mock-transfected control cells (Figure 6a ). De novo DNA methyltransferase activity in H292 cells was increased by 76% compared to control following DNMT3B transfection (Figure 6b ). MSP assay only detected the unmethylated PCR product in mock-transfected H292 cells. Transfection of pcDNA-DNMT3B into H292 cells directly resulted in the detection of methylated PCR product (Figure 6c) . The methylated and unmethylated PCR products were Figure 5 Correlation of SNCG expression with inhibited DNMT3B expression by CSE in A549 cells. (a) Analysis of DNMT1 expression by western blot. A549 cells were treated with 5% CSE for 1-3 days. Total cell lysate was isolated at the indicated times and analysed for DNMT1 protein expression by Western blotting. (b) Analyses of DNMT3A and DNMT3B mRNA expression by realtime RT-PCR. A549 cells were treated with 5% CSE for a period of 0-72 h. At the indicated time points, total RNA was isolated and quantitative real-time RT-PCR with predeveloped probes to human DNMT3A, DNMT3B and GADPH was conducted to assess the mRNA levels. After normalization with GAPDH, the abundance of DNMT3A or DNMT3B mRNA in untreated cells was defined as 1, and the amounts of each mRNA from CSE-treated cells were plotted relative to that value. The figure shown is representative of three independent experiments in which each sample was assayed in triplicates. The results are mean 7s.d. (c) CSE withdrawal. A549 cells were untreated or treated with 5% CSE for 3 days. Then the fresh medium without CSE was added to cells, and the cells were harvested for genomic DNA and total RNA isolations at the indicated time points. The methylation status of SNCG was determined by MSP, the SNCG mRNA expression was examined by RT-PCR and the mRNA levels of DNMT3B were assessed by quantitative real-time PCR. DNMT3B mRNA in untreated cells was defined as 1, and the amounts of DNMT3B mRNA from CSE-treated cells at different time points after CSE withdrawal were plotted relative to that value. (d) Blocking DNMT3B expression with siRNA induces SNCG mRNA expression. A549 cells were transfected with DNMT3B siRNA or a scrambled RNA (as control) for 3 days. The mRNA levels of SNCG and DNMT3B were assessed by RT-PCR (inset) and real-time quantitative RT-PCR.
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subsequently cloned separately into pCR2.1-TOPO cloning vector. After transformation into E. coli, plasmid DNAs isolated from individual colonies of each DNA sample were sequenced. The sequencing results clearly demonstrate that the methylated sequence of SNCG CpG island is associated with the DNMT3B-transfected H292 cells and the completely unmethylated CpG island is associated with the mock-transfected cells (Figure 6d) .
Finally, we compared the effects of exogenous overexpression of DNMT1 and DNMT3A with DNMT3B overexpression on SNCG expression in H292 cells. Western blot analysis using anti-SNCG antibody showed that the SNCG protein expression was only reduced in DNMT3B-transfected cells, but not in DNMT1-or DNMT3A-transfected cells (Figure 7) . These results together clearly demonstrate that SNCG is a target gene of DNMT3B, which keeps SNCG CpG island in a methylated state to silent its expression.
Discussion
This study shows differential effects by tobacco exposure on the expression level of the DNMTs. DNMT1 expression was induced by CSE in A549 cells. The increased abundance of DNMT1 was reflected by the hypermethylated status of RASSF1A and MGMT in CSE-treated cells as compared to control cells, which was consistent with previous literature reports (Burbee et al., 2001) . We also observed a moderate increase in the mRNA expression of DNMT3A. In contrast, the mRNA expression of DNMT3B was consistently downregulated by CSE with kinetics similar to that of CSE-induced SNCG demethylation. A withdrawal experiment demonstrated that the effect of CSE on SNCG demethylation was reversible. After the removal of CSE from the culture medium, the demethylated SNCG gene slowly reverted back to the methylated stage, and this change in methylation status correlated with the restoration of DNMT3B expression in a synchronized fashion. These data suggest that a certain cellular level of DNMT3B is required to maintain SNCG in a methylated state. Additional experiments using siRNA to inhibit DNMT3B expression further supported this hypothesis through the demonstration of an increased level of SNCG mRNA in A549 cells after the reducing DNMT3B expression by siRNA. These data support a functional role of DNMT3B in the maintenance of SNCG CpG island methylation. A previous study in HCT116 human colon cancer cells demonstrated the cooperation between DNMT3B and DNMT1 to maintain global DNA methylation as well as to maintain DNA methylation of a set of TSGs (Rhee et al., 2002) . With regard to SNCG, our study could not exclude the cooperative role of DNMT1 in silencing SNCG expression in A549 cells, as we did not use siRNA against DNMT1 to examine the requirement of this enzyme in the maintenance of SNCG CpG island methylation directly. However, as DNMT1 expression is induced by CSE in A549 cells and DNMT1 accounts for >90% of the maintenance activity of DNA methylation, it is unlikely that DNMT1 is involved in the maintenance of SNCG methylation. DNMT3B possesses de novo DNA methyltransferase activity along with DNMT3A and unmethylated DNA is the preferred substrate for these two enzymes (Lyko et al., 1999) . To examine the de novo methyltransferase activity of DNMT3B in controlling SNCG methylation status, H292 lung cancer cells in which the CpG island of SNCG is completely unmethylated were transfected with a DNMT3B expression vector. Both the enzymatic activity and the mRNA level of DNMT3B were elevated 
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H Liu et al in transfected cells as compared to mock-transfected cells. MSP and DNA sequencing clearly showed that overexpression of DNMT3B converted the unmethylated SNCG CpG island into an almost fully methylated island. The specificity of DNMT3B to methylate SNCG was further demonstrated by transfections of DNMT1, DNMT3A and DNMT3B into H292 cells. In contrast to DNMT3B, overexpression of DNMT1 or DNMT3A did not silence SNCG expression. In this study, we could not perform the chromatin immunoprecipitation assay to demonstrate the direct association of DNMT3B with SNCG CpG island owing to the unavailability of an effective anti-DNMT3B antibody. Nevertheless, the large amount of data presented in this study strongly suggests that DNMT3B regulates the methylation status of SNCG through its maintenance as well as de novo DNA methyltransferase activity. DNMT3A and DNMT3B are closely related with regard to their structure and function, yet these two enzymes have shown different substrate specificities. It was shown that inactivation of DNMT3B in mouse embryonic fibroblasts resulted in DNA hypomethylation, chromosomal instability and spontaneous immortalization, but these changes were not observed by inactivating DNMT3A (Dodge et al., 2005) . Another recent study reported that the first exon of the G isoform of fibroblast growth factor is the preferred substrate for DNMT3A but not for DNMT3B (Oka et al., 2006) . Our results in this study further show that these two enzymes are under different regulation by CSE, and that the CpG island of SNCG is a specific substrate of DNMT3B not DNMT3A.
CSE treatment consistently caused the demethylation of SNCG CpG island and induced the expression of SNCG mRNA expression, but we were able to detect SNCG protein expression in CSE-treated cells by Western blot. The fact that blocking SNCG expression with siRNAs during the CSE treatment largely reduced the ability of these cells to invade implies that even SNCG protein was not induced to detectable levels, it could still have a significant impact on the ability of cells to invade. The relationship between SNCG protein expression and cell invasion was further studied by using lung cancer cell line H292 that expresses SNCG at a high level owing to the complete demethylation of the CpG island. Repression of the endogenous SNCG expression by siRNA also inhibited invasion of the H292 cells. Our previous clinical study of 20 lung tumor samples detected SNCG expression in all seven tumor samples from patients with metastatic disease (7/7, 100%), whereas SNCG expression was considerably lower in lung tumors of patients without detectable metastasis (2/13, 15.3%) (Liu et al., 2005) . These clinical observations and the results of this current study support the role for SNCG as a prometastatic oncogene. Recently, it has been reported that the increased protein expressions of DNMT1, DNMT3A and DNMT3B were found in lung tumor samples by using immunohistochemical approach (Lin et al., 2006) . This study also presented some evidence to show a correlation between DNMT1 and DNMT3B overexpression with hypermethylation of TSG promoters, especially among smoking squamous carcinoma patients. The discrepancy between our findings with that report could result from different methods of detection. It is unknown whether the antibodies used in that report had cross reactivity among different methyltransferases. Alternatively, our in vitro studies in the lung cancer cells may not completely reflect the complex impact of smoke under in vivo situations.
In summary, we have demonstrated that tobacco exposure strongly induces the abnormal expression of SNCG in lung cancer cells through downregulation of DNMT3B. In addition, evidence is provided demonstrating a role for SNCG in lung cancer cells invasion.
Materials and methods

Cells and reagents
Human lung cancer cell lines A549 and H292 were obtained from America Type Culture Collection (Manassas, VA, USA). A549 cells were cultured in F12K medium supplemented with 10% fetal bovine serum (FBS) and H292 cells were cultured in RPMI-1640 (Mediatech, Inc., Herndon, VA, USA) with 10% FBS. CSE from type-2R1 research cigarettes (Kentucky Tobacco Research and Development Center, Lexington, KY, USA) (Mercer et al., 2004) was generated by a smoking machine (Type 1300; AMESA Electronics, Geneva, Switzerland) with 70 ml puff per 2 s and was collected by bubbling undiluted smoke through 10 ml phosphate-buffered saline (PBS). This solution (100%) was adjusted to pH 7.4, and filtered. The nicotine concentration of CSE was approximately 2.5 mg/ml. After preparations, CSE stock solutions were frozen in aliquots at À801C. 5-aza-C was purchased from Sigma (St Louis, MO, USA). Anti-SNCG was purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA) and anti-DNMT1, anti-DNMT3A and anti-DNMT3B were obtained from IMGENEX (San Diego, CA, USA). The plasmids pcDNA-DNMT3A and pcDNA-DNMT3B have been previously described (Loriot et al., 2006) and were generously provided by Dr Charles De Smet (LUDWIG Institute for Cancer Research, Brussels, Belgium). Synuclein-c is a target gene of DNMT3B H Liu et al
RT-PCR
Total RNA was isolated from untreated or CSE-treated cells. For analysing SNCG or DNMT3B mRNA expressions by RT-PCR, the reverse transcription was performed with Random Primers and M-MLV Reverse Transcriptase (Promega, Madison, WI, USA) at 371C for 1 h in a volume of 25 ml containing 2 mg of total RNA. The PCR was carried out at 941C for 30 s, 601C for 30 s and 721C for 30 s with initial activation of the enzyme at 941C for 90 s. Thirty cycles were performed for SNCG, DNMT3B and GAPDH. The primer sequences for SNCG, DNMT3B and GAPDH are listed in Supplementary  Table 1 .
Quantitative real-time RT-PCR The cellular expression levels of DNMT1, DNMT3A, DNMT3B and SNCG mRNAs were also examined by TaqMan real-time RT-PCR. Two microliters of the cDNA 1:10 diluted and TaqMan real-time primers and probes were used for amplification. A set of primers and a probe for each gene tested were obtained from Applied Biosystems (Foster City, CA, USA). Assay IDs for the genes are as follows: DNMT1, Hs00154749_m1; DNMT3A, Hs00173377_m1; DNMT3B, Hs00171876_m1 and SNCG, Hs00268306_m1. All PCR were carried out in TaqMan Universal PCR master mix (ABgene, Rochester, New York, NY, USA) and ABI Prism 7900-HT Sequence Detection System (Applied Biosystems). The relative mRNA expression level of individual gene for each sample was normalized for input RNA against GAPDH expression.
Western blot analyses of SNCG and DNMT1 expression Total cell lysates of A549 and H292 cells were used to conduct Western blot analysis for SNCG expression as described previously (13). For detection of DNMT1 protein expression, A549 cells were cultured in medium containing 10% FBS in the absence or presence of 5% CSE for 1-3 days. During the CSE treatment, medium was changed every day with fresh CSE added. At the end of treatment, cells were lysed in lysis buffer (50 mM Tris, pH 8, 1% NP-40, 0.25% sodium deoxycholate and 150 mM NaCl) containing a cocktail of protease inhibitors. Total protein (50 mg) was separated on 4-20% gradient sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to PVDF membranes, followed by incubating with anti-SNCG or anti-DNMT1 antibodies. Membranes were reprobed with anti-actin antibody to correct for the protein loading differences. The signals were detected using an ECL-plus Western detection system (Amersham, Buckinghamshire, UK) and were quantitated with the Image Station 440 (Kodak, Eastman Kodak company, Scientific Imaging Systems, Rochester, NY, USA).
Multiplex, nested methylation-specific PCR and genomic sequencing of bisulfite-modified DNA Genomic DNA was extracted from cells by using DNA isolation kit (Promega, Madison, WI, USA) following the vendor's protocol. DNA (2 mg) was modified by sodium bisulfite and purified (Palmisano et al., 2000) . Genomic sequencing and MNMSP analysis of SNCG CpG island in control and CSE-treated cells were performed as described previously (Liu et al., 2005 ). An MNMSP approach was developed in this study to examine the changes in methylation status of the promoter regions of TSGs RASSF1A and MGMT, oncogene uPA, and the exon 1 region of SNCG. All primer sequences are listed in Supplementary Table 1. Step 1 was performed by using all four primer sets together in one PCR. The primers flanked the CpG-rich regions within the promoters of the respective genes and amplified the sodium bisulfite-modified DNA regardless of the methylation status of the gene. For step 1, PCR were carried out in a volume of 25 ml containing Â 1 PCR buffer, Â 1 TaqMaster PCR Enhancer, 0.25 mM deoxyribonucleotide triphosphate, 25 pmol of each primer and 1.25 units of platinum Taq polymerase (Eppendorf AG, Hamburg, Germany). The reactions were carried out at 941C for 1 min to activate the hot start enzyme; then 38 cycles of 941C for 30 s, 521C for 30 s and 721C for 30 s, and a final extension at 721C for 5 min were carried out. PCR products from step 1 reactions were diluted 1:10 in ddH 2 O, and 4 ml was used as DNA template in step 2 of the nested PCRs (25 ml reaction volume with the components listed above) using the following conditions: 941C for 1.5 min; then 20-30 cycles of denature at 941C for 30 s, anneal at 601C (RASSF1A), 601C (MGMT), 541C (uPA), 601C (SNCG) for 30 s and extension at 721C for 30 s, with a final extension at 721C for 5 min. PCR products from step 2 reactions were analysed on 2% agarose gels.
Cell proliferation assay A549 cells were seeded in 24-well culture plates at a density of 1 Â 10 4 cells/well and cultured in 0.5 ml medium containing 10% FBS without or with 5% CSE. At indicated times, cells were trypsinized and viable cells (trypan blue excluding cells) were counted. Values are the mean of triplicate wells.
Boyden chamber invasion assay A549 cells were treated with 0, 1.2 and 5% CSE for 3 days. Cells were trypsinized and the invasive capacities of cells were then determined using two-compartment Boyden chambers (Transwell, Costar, Cambridge, MA, USA) and the basement membrane matrigel (BD Bioscience Discovery Labware, Bedford, MA, USA). The 8 mm pore polycarbonate filters were coated with matrigel (25 ml per filter). About 5 Â 10 4 cells in 0.1 ml of medium were added to the upper chamber and placed on top of a lower chamber prefilled with 0.8 ml of serum-free medium and then incubated at 371C for 40 h. After the incubation, medium was removed and the filters were fixed, washed and stained using the HEMA3 Stain Set from Fisher (Middletown, VA, USA). Cells that remained on the top chamber were removed using a cotton swap. Cells that invaded to the bottom chambers were examined under a light microscope. Under Â 200 magnification, 10 randomly selected fields per filter were examined and the total numbers of cells invaded per field were counted.
Small interference RNA (siRNA) transfection Predesigned siRNAs targeted to human SNCG (Catalogue No.16704, siRNA ID: 46044 and 6514), DNMT3B (Catalogue No. 16708, siRNA ID: 111744 and 18955) and a negative control with a scrambled sequence (Catalogue No. 4618G) were obtained from Ambion (Austin, TX, USA). For siRNA transfection, RNA was mixed with OPTIMEM-1 medium (Invitrogen, Carlsbad, CA, USA), siPORT NeoFX (Ambion) at room temperature for 10 min. The RNA/transfection complex was then mixed with 2.3 Â 10 5 cells per well and cells were seeded in 6-well plate. After 1 day, transfected cells were untreated or treated with 5% CSE for 3 days before Boyden chamber invasion assay.
Transient plasmid transfections H292 cells were transfected with plasmid DNA by using FuGENE 6 transfection reagent (Roche Diagnostics, Indianapolis, IN, USA). Briefly, H292 cells were seeded in 60 mm dishes at a density of 4 Â 10 5 per dish overnight before the transfection. Transfection was performed by using FuGENE 6 Transfection Reagent (6 ml) in the 3:1 ratios to plasmid DNA (2 mg) per dish. Three days after transfection, nuclear extract, whole cell lysate, total RNA and genomic DNA were separately isolated for measuring the de novo DNMT activity, Western blotting, RT-PCR, real-time PCR and MSP.
Preparation of nuclear extracts Nuclear extracts were prepared by using the nuclear extraction kit (Panimics, Redwood City, CA, USA). Briefly, subconfluent H292 cells seeded in 100 mm culture dish were washed twice with cold PBS. Cells were lysed in lysis buffer containing 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) pH 7.9, 10 mM KCl, 10 mM ethylenediaminetetraacetic acid (EDTA), 1 mM dithiothreitol (DTT), 0.4% octylphenoxy poly(ethyleneoxy)ethanol (IGEPAL CA 630) and protease inhibitor cocktail (Complete mini, Roche Diagnostics Corporation, Indianapolis, IN, USA), under constant shaking for 10 min. Cells were scraped off the dish and mixed by repeated pipetting to disrupt cell clumps. The lysate was centrifuged at 15 000 g for 3 min at 41C. The supernatant was discarded and the nuclear pellet was resuspended in 150 ml of buffer B (20 mM HEPES, pH 7.9, 400 mM NaCl, 1 mM EDTA, 10% glycerol, 1 mM DTT and protease inhibitor cocktail), and vigorously mixed by vortexing for 10 s followed by continuously rocking at 01C for 2 h. The extract was then centrifuged at 15 000 g for 5 min at 41C and the supernatant was collected.
After measuring the protein concentration with the BCA Protein Assay Kit (Pierce, Rockford, IL, USA), the nuclear extract was aliquoted and stored at À801C.
De novo DNA methyltransferase activity assay The DNA methyltransferase assay was performed as described previously (Belinsky et al., 1996; Patra et al., 2006; Guo et al., 2002) with some modification. Twenty micrograms of nuclear extract was incubated at 371C with 1.5 mg of unmethylated poly(dI-dC)-poly(dI-dC) (Sigma) as the template and 2 mCi of 3 H-labeled S-adenosylmethionine (Amersham Biosciences, Piscataway, NJ, USA) in a total volume of 40 ml of reaction buffer (pH 7.4), containing 20 mM Tris-HCl, 25% glycerol (v/v), 10 mM EDTA, 0.2 mM phenylmethylsulfonyl fluoride and 20 mM 2-mercaptoethanol. Poly(dI-dC)-poly(dI-dC) was specifically chosen because the enzyme was reported to have a high activity to this substrate (Pfeifer and Drahovsky, 1986) . After 2 h, reactions were stopped by adding 300 ml of solution containing 1% sodium dodecyl sulfate, 2.0 mM EDTA, 3% 4-aminosalicylate, 5% butanol, 125 mM NaCl, 0.25 mg/ml carrier salmon testes DNA and 1 mg/ml protease K and were further incubated for 30 min. Protein was extracted twice with phenol-chloroform-isoamyl and chloroform. The reacted DNA template was precipitated by ethanol and resuspended in 30 ml of 0.3 M NaOH at 371C for 60 min. The solution was spotted onto GF/C Whatman filter. After drying, filters were washed with ice-cold 5% trichloroacetic acid containing 60 mg/ ml bovine serum albumin, followed by 70% ethanol. Filters were dried and placed in vials with scintillation fluid and counted on a scintillation counter (Beckman Coulter, Inc., Fullerton, CA, USA, 2200CA 
